Retraction notice to "CRISPLD1 promotes gastric cancer progression by regulating the Ca/PI3K-AKT signaling pathway" [Heliyon 10 (2024) e27569].
[This retracts the article DOI: 10.1016/j.heliyon.2024.e27569.].
APA
Hu L, Shi J, et al. (2025). Retraction notice to "CRISPLD1 promotes gastric cancer progression by regulating the Ca/PI3K-AKT signaling pathway" [Heliyon 10 (2024) e27569].. Heliyon, 11(16), e44092. https://doi.org/10.1016/j.heliyon.2025.e44092
MLA
Hu L, et al.. "Retraction notice to "CRISPLD1 promotes gastric cancer progression by regulating the Ca/PI3K-AKT signaling pathway" [Heliyon 10 (2024) e27569].." Heliyon, vol. 11, no. 16, 2025, pp. e44092.
PMID
41395383
Abstract
[This retracts the article DOI: 10.1016/j.heliyon.2024.e27569.].
같은 제1저자의 인용 많은 논문 (5)
- Efficacy and safety of botulinum toxin A in the treatment of female pattern hair loss.
- Blockade of CD47 signaling improves ferroptosis of lung cancer cells via activating Nrf2/FPN signaling.
- A functional NKILA variant (rs2273534) drives genetic susceptibility and oncogenic progression in gastric cancer via the miR-4424/OAS2 pathway.
- A real-world multicenter study of first-line zanubrutinib-based therapy for diffuse large B-cell lymphoma.
- A cross-sectional curvey study on the correlation between irrational drug use in diabetic patients and the occurrence of malignant tumors.